106 results on '"Cao, Davide"'
Search Results
2. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
3. Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week
4. Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7
5. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI
6. TCT-168 Clinical Significance of Insulin- and Noninsulin-Dependent Diabetes in Patients Undergoing Percutaneous Revascularization of the Left Main Coronary Artery
7. TCT-728 Impact of Neutrophil-to-Lymphocyte Ratio on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
8. TCT-433 Clinical and Procedural Outcomes of Percutaneous Coronary Intervention for De Novo Lesions involving the Ostial Left Circumflex Coronary Artery
9. IMPACT OF SEX ON OUTCOMES AMONG PATIENTS WITH A PREVIOUS CORONARY ARTERY BYPASS GRAFT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
10. ONE- VERSUS THREE-MONTH DAPT IN OLDER PATIENTS AT HIGH BLEEDING RISK UNDERGOING PCI: INSIGHTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM
11. TCT-4 Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation
12. TCT-158 Pooled Analysis of Patients Undergoing Complex PCI With the Dual-Therapy COMBO Stent: The MEGA-COMBO Complex-PCI Analysis
13. TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI
14. TCT-566 Impact of Sex on Risk for Adverse Events Associated With Polyvascular Disease in Patients After PCI
15. TCT-381 Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
16. Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG
17. IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL
18. TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL
19. PREDICTORS OF ANTIPLATELET CESSATION IN A REAL-WORLD PATIENT POPULATION WITH CORONARY STENTS UNDERGOING NONCARDIAC SURGERY
20. PROGNOSTIC VALUE OF HIGH SENSITIVITY C-REACTIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
21. IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL
22. TCT-228 Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study
23. TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis
24. TCT-39 Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index: TWILIGHT-BMI Analysis
25. TCT-217 Predictors of Dyspnea in Patients Receiving Ticagrelor After PCI: Insights From the Twilight Trial
26. TCT-346 The Mega COMBO Collaboration: An Individual Patient Data Pooled Analysis of Patients Undergoing PCI With COMBO Stent
27. PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI
28. PROGNOSTIC VALUE OF ELEVATED C-REACTIVE PROTEIN AMONG DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
29. IMPACT OF TARGET VESSEL CHOICE ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH A PRIOR CORONARY ARTERY BYPASS GRAFT
30. BLEEDING RISK IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
31. TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY
32. PREVALENCE AND PROGNOSTIC IMPACT OF HIGH BLEEDING RISK STATUS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE
33. SAFETY AND EFFICACY OF 1-MONTH VERSUS 3-MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS WITH AN EVEROLIMUS ELUTING STENT: INSIGHTS FROM THE XIENCE SHORT DAPT PROGRAM
34. TCT CONNECT-162 Predictors of Adverse Events in Patients Undergoing Cardiac Surgery Within 1 Year of PCI
35. TCT CONNECT-305 Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis
36. TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry
37. TCT CONNECT-379 Adverse Outcomes in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease
38. TCT CONNECT-47 Impact of Sex at Birth on Long-Term Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
39. TCT CONNECT-307 Long-Term Outcomes After Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis According to Diabetes Mellitus Status
40. TCT CONNECT-378 Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single-Center Large-Volume PCI Registry
41. TCT CONNECT-56 Prolonged Dual Antiplatelet Therapy in Patients With or Without Prior Myocardial Infarction: An Updated Systematic Review and Meta-Analysis
42. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients
43. HIGH BLEEDING RISK AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT OF RACE/ETHNICITY
44. ADDITIVE EFFECT OF MULTIPLE HIGH BLEEDING RISK CRITERIA IN PATIENTS UNDERGOING PCI
45. PERFORMANCE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA ACCORDING TO SEX
46. THE EFFECT OF COMPLEX CORONARY REVASCULARIZATION PROCEDURE IN PATIENTS AT HIGH-BLEEDING RISK
47. Ticagrelor Monotherapy After Coronary Stenting
48. TCT-833 Inflammatory Risk Status Is Age-Dependent in Women but Not in Men Undergoing Percutaneous Coronary Intervention
49. TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention
50. TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.